Opportunity Information: Apply for RFA DA 23 004
The Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures is a National Institutes of Health (NIH) funding opportunity (RFA-DA-23-004) that uses a U01 cooperative agreement mechanism and does not allow clinical trials. The central goal is to generate and expand central nervous system (CNS) single-cell datasets that help researchers pinpoint the molecular signatures of individual cell types that are relevant to substance use disorders (SUDs) and to HIV persistence, including processes tied to HIV replication, latency, and reservoir biology. The emphasis is on exploiting modern single-cell and single-nucleus approaches, not just at the level of gene expression, but also across other layers of regulation such as the epigenome and nucleome, along with other emerging single-cell assays that can capture cell identity, state, and regulatory control with high resolution.
Scientifically, the opportunity is aimed at mapping how chronic exposure to opioids and other commonly co-used substances (specifically methamphetamine, cocaine, and/or cannabinoids) affects CNS cellular populations and their molecular programs, especially in contexts that intersect with HIV. In practical terms, the initiative is meant to enable a clearer, cell-by-cell view of which CNS cells show distinctive transcriptional or regulatory patterns linked to substance exposure, which cell types may be more permissive or resilient to HIV-related mechanisms, and how substance exposure might reshape cellular environments in ways that influence HIV persistence or immune and glial responses in the brain. By focusing on single-cell transcriptomic, epigenomic, nucleomic, and related assays, the program is aligned with building detailed reference-quality datasets that can support downstream hypothesis generation, target discovery, and cross-study comparisons in neuroHIV and addiction research.
From a funding and administrative standpoint, this is a discretionary federal opportunity in the Education and Health activity area, listed under CFDA 93.279, with NIH as the sponsoring agency. The U01 cooperative agreement format generally indicates substantial scientific involvement or partnership expectations from NIH program staff compared to a standard investigator-initiated grant, and it often fits projects where coordination, data generation standards, or shared resources are important. The posted original closing date for applications was 2022-08-11, and the source excerpt does not specify an award ceiling or expected number of awards, implying those details would normally be found in the full announcement and related NIH documentation.
Eligibility is broad and includes a wide range of domestic and certain non-domestic organizations. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other organizations. The opportunity explicitly highlights additional eligible applicant types as well, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, non-domestic (non-U.S.) entities (foreign organizations), Indian/Native American Tribal Governments (other than federally recognized), and U.S. territories or possessions. This breadth signals an intent to encourage participation across many institutional contexts, including organizations serving underrepresented communities and entities outside the continental U.S., consistent with building broadly useful CNS single-cell resources and expertise.
Overall, the SCORCH Program Expansion opportunity is best understood as a data-generation and discovery-enabling initiative centered on high-resolution, single-cell molecular profiling of CNS tissues or models relevant to chronic substance exposure and HIV-related biology. The expected output is the kind of cell-type- and cell-state-specific molecular information that traditional bulk assays cannot provide, with the longer-term purpose of clarifying mechanisms at the intersection of addiction and neuroHIV, and accelerating the identification of cellular targets or pathways that could inform future research and intervention strategies.Apply for RFA DA 23 004
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2022-03-15.
- Applicants must submit their applications by 2022-08-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: NIJ FY22 Research and Evaluation on Violent Crime and Firearm Violence in the Community
Previous opportunity: U.S. Embassy Buenos Aires PAS Annual Program Statement
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 23 004
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 23 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) Apply for RFA DA 23 014 Funding Number: RFA DA 23 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 22 017 Funding Number: RFA CA 22 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) Apply for PAR 22 126 Funding Number: PAR 22 126 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Focused Technology Research and Development (R01 Clinical Trial Not Allowed) Apply for PAR 22 127 Funding Number: PAR 22 127 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 22 023 Funding Number: RFA CA 22 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 22 024 Funding Number: RFA CA 22 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Apply for RFA CA 22 022 Funding Number: RFA CA 22 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) Apply for RFA CA 22 021 Funding Number: RFA CA 22 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 013 Funding Number: RFA CA 22 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) Apply for RFA CA 22 012 Funding Number: RFA CA 22 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional) Apply for RFA DA 23 021 Funding Number: RFA DA 23 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 025 Funding Number: RFA AI 22 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional) Apply for PAR 22 145 Funding Number: PAR 22 145 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional) Apply for RFA CA 22 016 Funding Number: RFA CA 22 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) Apply for RFA CA 22 020 Funding Number: RFA CA 22 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 22 025 Funding Number: RFA CA 22 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: $2,000,000 |
| Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required) Apply for RFA DA 23 002 Funding Number: RFA DA 23 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) Apply for PAR 22 161 Funding Number: PAR 22 161 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) Apply for PAR 22 147 Funding Number: PAR 22 147 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Apply for PAR 22 136 Funding Number: PAR 22 136 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 23 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
